NIBAN2
Basic information
Region (hg38): 9:127505339-127578989
Previous symbols: [ "C9orf88", "FAM129B" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NIBAN2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 56 | 57 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 56 | 3 | 0 |
Variants in NIBAN2
This is a list of pathogenic ClinVar variants found in the NIBAN2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
9-127506970-C-A | not specified | Uncertain significance (Jan 10, 2023) | ||
9-127506999-G-A | not specified | Uncertain significance (Feb 06, 2023) | ||
9-127507008-G-A | not specified | Uncertain significance (Nov 15, 2021) | ||
9-127507027-C-T | not specified | Uncertain significance (Oct 27, 2022) | ||
9-127507036-G-A | not specified | Uncertain significance (Jan 10, 2023) | ||
9-127507135-T-C | not specified | Uncertain significance (Jan 04, 2024) | ||
9-127507146-G-A | not specified | Uncertain significance (Nov 23, 2021) | ||
9-127507155-G-A | not specified | Uncertain significance (Feb 05, 2024) | ||
9-127507234-G-A | not specified | Uncertain significance (Nov 08, 2022) | ||
9-127507236-C-T | not specified | Uncertain significance (Sep 22, 2022) | ||
9-127507248-G-A | not specified | Uncertain significance (May 17, 2023) | ||
9-127507297-C-T | not specified | Uncertain significance (Sep 17, 2021) | ||
9-127507324-C-T | not specified | Uncertain significance (May 23, 2024) | ||
9-127507333-C-T | not specified | Uncertain significance (Jun 27, 2023) | ||
9-127507414-C-G | not specified | Uncertain significance (Mar 01, 2024) | ||
9-127507930-T-A | not specified | Uncertain significance (Jul 13, 2021) | ||
9-127507935-C-G | not specified | Uncertain significance (Mar 31, 2024) | ||
9-127508149-G-C | not specified | Uncertain significance (Dec 13, 2023) | ||
9-127508151-G-A | not specified | Uncertain significance (Oct 26, 2021) | ||
9-127508194-C-T | not specified | Uncertain significance (Aug 12, 2021) | ||
9-127508457-T-G | not specified | Uncertain significance (Aug 04, 2023) | ||
9-127508523-C-T | not specified | Uncertain significance (Sep 22, 2022) | ||
9-127509055-C-T | not specified | Uncertain significance (Apr 05, 2024) | ||
9-127509061-G-A | not specified | Uncertain significance (Mar 05, 2024) | ||
9-127509076-T-C | not specified | Uncertain significance (Jun 14, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NIBAN2 | protein_coding | protein_coding | ENST00000373312 | 14 | 73651 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0170 | 0.983 | 125706 | 0 | 42 | 125748 | 0.000167 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.419 | 445 | 471 | 0.946 | 0.0000309 | 4835 |
Missense in Polyphen | 129 | 159.39 | 0.80931 | 1595 | ||
Synonymous | 0.688 | 206 | 219 | 0.941 | 0.0000161 | 1485 |
Loss of Function | 4.44 | 12 | 43.6 | 0.275 | 0.00000273 | 408 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000181 | 0.000181 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000359 | 0.000326 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000252 | 0.000220 |
Middle Eastern | 0.000359 | 0.000326 |
South Asian | 0.000101 | 0.0000980 |
Other | 0.000675 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: May play a role in apoptosis suppression. May promote melanoma cell invasion in vitro. {ECO:0000269|PubMed:19362540, ECO:0000269|PubMed:21148485}.;
Recessive Scores
- pRec
- 0.108
Intolerance Scores
- loftool
- 0.717
- rvis_EVS
- -1.35
- rvis_percentile_EVS
- 4.63
Haploinsufficiency Scores
- pHI
- 0.246
- hipred
- Y
- hipred_score
- 0.554
- ghis
- 0.571
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.996
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Fam129b
- Phenotype
Gene ontology
- Biological process
- axon guidance;negative regulation of cell population proliferation;negative regulation of angiogenesis;cell differentiation;negative regulation of vascular endothelial growth factor receptor signaling pathway;gonadotropin secretion;positive regulation of embryonic development;negative regulation of apoptotic process;hypomethylation of CpG island;negative regulation of Notch signaling pathway;negative regulation of transcription, DNA-templated;positive regulation of transcription, DNA-templated;positive regulation of skeletal muscle fiber development;negative regulation of DNA biosynthetic process;positive regulation of transcription regulatory region DNA binding
- Cellular component
- nucleus;nucleoplasm;cytoplasm;cytosol;plasma membrane;adherens junction;extracellular exosome
- Molecular function
- transcription coactivator activity;cadherin binding